Hayat Pharmaceutical Industries Co. PLC

Hayat Pharmaceutical Industries Co. PLC develops and manufactures pharmaceutical medicines from Amman, with dosage forms spanning multiple therapeutic classes. Its portfolio addresses allergies, cardiovascular conditions, dermatology, gastrointestinal health, infectious disease, neurology, pain and inflammation, respiratory care, vitamins and supplements, and men's and women's health. The company develops domestic brands for regional markets and places particular emphasis on generic medicines introduced first to market. Products include treatments based on established active ingredients such as cetirizine, losartan, rosuvastatin, amlodipine, clindamycin, famotidine, lansoprazole, and omeprazole.

Manufacturing operations follow cGMP, international guidelines, and regulatory requirements, with controls intended to protect the identity, strength, quality, and purity of drug products. Quality assurance is integrated with risk management across premises and manufacturing activities. The company has also invested in an overseas manufacturing plant built to US FDA standards, expanding its production capacity and creating scope for additional dosage forms and drug delivery systems. Skilled pharmaceutical personnel underpin this manufacturing and development work, alongside an operating focus on social responsibility, sustainability, community engagement, and continued expansion in regional and global pharmaceutical markets.